No Data
No Data
CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
CASI Pharmaceuticals Shares Are Trading Higher After the Company Announced Plans to Submit an Investigational New Drug Application to the FDA for CID-103 for the Treatment of Antibody-mediated Rejection in Kidney Transplant Recipients. Also, the...
CASI Pharmaceuticals Shares Are Trading Higher After the Company Announced Plans to Submit an Investigational New Drug Application to the FDA for CID-103 for the Treatment of Antibody-mediated Rejecti
Market-Moving News for June 27th
CASI: 92% | CASI Pharmaceuticals Announced Plan To Submit CID-103 IND Application; Also Announces Receipt Of A Non-binding Proposal To Acquire Its China Business For Aggregate Purchase Price Of $40MME
US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data
US stock futures were trending slightly lower in Thursday's premarket activity ahead of a slew of economic data coming out this morning, including Q1 GDP growth, weekly jobless claims, and durable goo
Top Premarket Gainers
Assure Holdings (IONM) shares were up 180% in recent Thursday premarket activity, adding to Wednesday's 3% gain. CASI Pharmaceuticals (CASI) stock was up 43%, a day after the company said it planned t
CASI Pharmaceuticals Sees Dramatic After-Hours Surge
CASI Pharmaceuticals, Inc. (NASDAQ: CASI) had an uneventful trading session on Wednesday, with the stock dipping slightly by 1.2%. However, after the close of regular trading hours, the stock saw a significant after-hours surge, climbing by as much as 65%. The volume was about three times higher than the average, indicating strong buying interest among ...